logo
explain how to read the page

The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers 10
  • 1
    Sore, Hannah Fiona, Dr
    Born in July 1977
    Individual (3 offsprings)
    Officer
    2016-10-17 ~ now
    OF - Director → CIF 0
    Dr Hannah Fiona Sore
    Born in July 1977
    Individual (3 offsprings)
    Person with significant control
    2016-10-17 ~ 2020-05-01
    PE - Ownership of shares – More than 25% but not more than 50%CIF 0
  • 2
    Blundy, Keith Stuart, Dr
    Born in April 1960
    Individual (15 offsprings)
    Officer
    2022-11-18 ~ now
    OF - Director → CIF 0
  • 3
    Moore, Jeffrey Bernard, Mr.
    Born in September 1965
    Individual (3 offsprings)
    Officer
    2022-11-18 ~ now
    OF - Director → CIF 0
  • 4
    Ford, David Ian
    Born in June 1974
    Individual (17 offsprings)
    Officer
    2025-01-15 ~ now
    OF - Director → CIF 0
  • 5
    Mcpartland, Peter
    Company Director born in January 1954
    Individual (23 offsprings)
    Officer
    2020-04-29 ~ 2025-01-15
    OF - Director → CIF 0
  • 6
    Fryers, Gaynor Mary
    Independent Consultant born in March 1957
    Individual (2 offsprings)
    Officer
    2019-04-06 ~ 2023-11-29
    OF - Director → CIF 0
  • 7
    Martin, Christine Janet, Dr
    Head Of Life Science Investment born in December 1969
    Individual (6 offsprings)
    Officer
    2020-04-29 ~ 2022-11-18
    OF - Director → CIF 0
  • 8
    Collins, Ian James, Dr
    Born in May 1967
    Individual (1 offspring)
    Officer
    2023-12-19 ~ now
    OF - Director → CIF 0
  • 9
    Mateu, Natalia, Dr
    Scientist born in August 1983
    Individual (1 offspring)
    Officer
    2017-07-18 ~ 2022-11-18
    OF - Director → CIF 0
    Dr Natalie Mateu
    Born in August 1983
    Individual (1 offspring)
    Person with significant control
    2017-07-18 ~ 2020-05-01
    PE - Ownership of shares – More than 25% but not more than 50%CIF 0
  • 10
    Dancer, Jane Elizabeth, Dr
    Born in February 1963
    Individual (9 offsprings)
    Officer
    2019-12-11 ~ now
    OF - Director → CIF 0
parent relation
Company in focus

PHARMENABLE THERAPEUTICS LIMITED

Period: 2023-07-20 ~ now
Company number: 10430444
Registered names
PHARMENABLE THERAPEUTICS LIMITED - now
PHARMENABLE LIMITED - 2023-07-20
Standard Industrial Classification
74909 - Other Professional, Scientific And Technical Activities N.e.c.
Brief company account
Property, Plant & Equipment
3,078 GBP2026-01-31
6,328 GBP2025-03-31
Debtors
244,428 GBP2026-01-31
398,989 GBP2025-03-31
Cash at bank and in hand
718,877 GBP2026-01-31
1,709,616 GBP2025-03-31
Current Assets
963,305 GBP2026-01-31
2,108,605 GBP2025-03-31
Creditors
Current, Amounts falling due within one year
-123,451 GBP2026-01-31
-169,979 GBP2025-03-31
Net Current Assets/Liabilities
839,854 GBP2026-01-31
1,938,626 GBP2025-03-31
Total Assets Less Current Liabilities
842,932 GBP2026-01-31
1,944,954 GBP2025-03-31
Equity
Called up share capital
32 GBP2026-01-31
32 GBP2025-03-31
Share premium
8,019,741 GBP2026-01-31
8,019,741 GBP2025-03-31
Retained earnings (accumulated losses)
-7,176,841 GBP2026-01-31
-6,074,819 GBP2025-03-31
Equity
842,932 GBP2026-01-31
1,944,954 GBP2025-03-31
Average Number of Employees
132025-04-01 ~ 2026-01-31
172024-04-01 ~ 2025-03-31
Property, Plant & Equipment - Gross Cost
Other
30,762 GBP2025-03-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
Other
27,684 GBP2026-01-31
24,434 GBP2025-03-31
Property, Plant & Equipment - Increase From Depreciation Charge for Year
Other
3,250 GBP2025-04-01 ~ 2026-01-31
Property, Plant & Equipment
Other
3,078 GBP2026-01-31
6,328 GBP2025-03-31
Trade Debtors/Trade Receivables
Current
38,735 GBP2026-01-31
0 GBP2025-03-31
Amount of corporation tax that is recoverable
Current
171,518 GBP2026-01-31
278,016 GBP2025-03-31
Other Debtors
Current, Amounts falling due within one year
34,175 GBP2026-01-31
120,973 GBP2025-03-31
Debtors
Current, Amounts falling due within one year
244,428 GBP2026-01-31
398,989 GBP2025-03-31
Trade Creditors/Trade Payables
Current
50,064 GBP2026-01-31
96,395 GBP2025-03-31
Other Taxation & Social Security Payable
Current
5,436 GBP2026-01-31
0 GBP2025-03-31
Other Creditors
Current
67,951 GBP2026-01-31
73,584 GBP2025-03-31
Creditors
Current
123,451 GBP2026-01-31
169,979 GBP2025-03-31

  • PHARMENABLE THERAPEUTICS LIMITED
    Info
    PHARMENABLE LIMITED - 2023-07-20
    Registered number 10430444
    C/o Azets, Victory House Vision Park, Histon, Cambridge, Cambridgeshire CB24 9ZR
    PRIVATE LIMITED COMPANY incorporated on 2016-10-17 (9 years 6 months). The status of the company number is Active.
    The last date of confirmation statement was made at 2026-02-25
    CIF 0
child relation
Offspring entities and appointments 0
  • Not found in our database.

The content of this website is protected by AgonGuard.

© 2022- Polylogarithmic Technology Ltd (Registered in England and Wales No. 14256313). All rights reserved.

Contains public sector information retrieved at 5 April 2026 and licensed under the Open Government Licence v3.0.